Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R ... - SYS-CON Media (press release)

Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R ... SYS-CON Media (press release), NJ Ankylosing spondylitis (AS) is a debilitating condition that affects three times as many men as women. It typically causes inflammation and pain in the spine (known as axial disease), but can also affect the peripheral joints. As a result of this pain, ...

Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R ... - APA OTS (Pressemitteilung)

Wyeth Presents New Analyses of Data From Three Studies of ENBREL(R ... APA OTS (Pressemitteilung), Austria **The ASCEND Study Ankylosing spondylitis (AS) is a debilitating condition that affects three times as many men as women. It typically causes inflammation and pain in the spine (known as axial disease), but can also affect the peripheral joints. ...

NIMS Gets FDA Grants OK to Expand Exer-Rest Indications to Include ... - Trading Markets (press release)

NIMS Gets FDA Grants OK to Expand Exer-Rest Indications to Include ... Trading Markets (press release), CA Morning stiffness is also prevalent in osteoarthritis, polymyalgia rheumatica, ankylosing spondylitis, psoriatic arthritis, and Achilles tendonopathy. A home interview survey conducted by others in over 4000 persons above age 55 years revealed the ...

Johnson & Johnson - Wealthy & Healthy? - Trading Markets (press release)

Johnson & Johnson - Wealthy & Healthy? Trading Markets (press release), CA April 24 - The FDA approved Simponi, generically known as golimumab for the treatment of moderately to severely active rheumatoid arthritis, active psoriatic arthritis and active ankylosing spondylitis. According to some analysts, the approval of ...